Demonstration of recurrent dedifferentiated liposarcoma of the spermatic cord by FDG-PET

Richie JP. Neoplasms of the testis.In: Walsh PC, Retik AB, Stamey TA, Darracott Vaughan E, eds. Campbell’s Urology. 6th ed. Vol. 2. Philadelphia, Pa: Saunders, pp. 1222–1263, 1992.

Lioe TF, Biggart JD. Tumours of the spermatic cord and paratesticular tissue. A clinicopathological study.Brit J Urol 71: 600–606, 1993.

Sogani PC, Grabstald H, Whitmore WF Jr. Spermatic cord sarcoma in adults.J Urol 120: 301–305, 1978.

Bellinger MF, Gibbons MD, Koontz WW Jr, Graff M. Paratesticular liposarcoma.Urology 11: 285–288, 1978.

Gowing NF, Morgan AD. Paratesticular tumors of connective tissue and muscle.Brit J Urol 36 (Suppl): 78–84, 1964.

Samellas W. Malignant neoplasms of spermatic cord.NY State J Med 64: 1213–1215, 1964.

El-Badawi AA, Al-Ghorab MM. Tumors of the spermatic cord: a review of the literature and a report of a case of lymphangioma.J Urol 94: 445–450, 1965.

Arlen M, Grabstald H, Whitmore WF Jr. Malignant tumors of the spermatic cord.Cancer 23: 525–532, 1969.

Beccia DJ, Krane RJ, Olsson CA. Clinical management of non-testicular intrascrotal tumors.J Urol 116: 476–479, 1976.

Vorstman B, Block NL, Politano VA. The management of spermatic cord liposarcoma.J Urol 131: 66–69, 1984.

Wahl RL. Positron emission tomography: application in oncology.In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh: Churchill Livingstone, pp. 801–882, 1994.

Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, et al. Work in progress. [18F]fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.Radiology 144: 885–889, 1982.

Strauss LG, Clorius JH, Schlag P, Lehner B, Kimmig B, Engenhart R, et al. Recurrence of colorectal tumors: PET evaluation.Radiology 170: 329–332, 1989.

Ito K, Kato T, Tadokoro M, Ishiguchi T, Oshima M, Ishigaki T, et al. Recurrent rectal cancer and scar: differentiation with PET and MR imaging.Radiology 182: 549–552, 1992.

Haberkorn U, Strauss LG, Dimitrakopoulou A, Engenhart R, Oberdorfer F, Ostertag H, et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy.J Nucl Med 32: 1485–1490, 1991.

Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment to response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 32: 1655–1660, 1991.

Wahl RL, Zasadny KR, Helvie M, Hutchins GD, Weber B, Cody R. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography (PET): initial evaluation.J Clin Oncology 11: 2101–2111, 1993.

Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-d-glucose: variations with body weight and a method for correction.Radiology 189: 847–850, 1993.

Bush CH, Spanier SS, Gillespy T III. Imaging of atypical lipoma of the extremities: a report of three cases.Skel Radiol 17: 472–475, 1988.

Kransdorf MJ, Moser RP Jr, Meis JM, Meyer CA. Fatcontaining soft tissue masses of the extremities.Radiographics 11: 81–106, 1991.

Jelinek JS, Kransdorf MJ, Shmookler BM, Aboulafia AJ, Malawer MM. Liposarcoma of the extremities: MR and CT findings in the histologic subtypes.Radiology 186: 455–459, 1993.

London J, Kim EE, Wallace S, Shirkhoda A, Coan J, Evans H. MR imaging of liposarcoma: correlation of MR features and histology.J Comput Assist Tomogr 15: 832–835, 1989.

Kern KA, Brunetti A, Norton JA, Chang AE, Malawer M, Lack E, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET.J Nucl Med 29: 181–186, 1988.

Adler LP, Blair HF, Makley JT, Williams RP, Joyce MJ, Leisure G, et al. Noninvasive grading of musculoskeletal tumors using PET.J Nucl Med 32: 1508–1512, 1991.

Griffeth LK, Dehdashti F, McGuire AH, McGuire DJ, Perry DJ, Moerlein SM, et al. PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-d-glucose.Radiology 182: 185–194, 1992.

Nieweg OE, Pruim J, van Ginkel RJ, Hoekstra HJ, Paans AMJ, Molenaar WM, et al. Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.J Nucl Med 37: 257–261, 1996.

Schifter T, Hoffman JM, Hanson MW, Boyko OB, Beam C, Paine S, et al. Serial FDG-PET studies in the prediction of survival in patients with primary brain brain tumor.J Comput Assist Tomogr 17: 509–516, 1993.